Abstract
The symptoms and suffering of the dying patient can be distressful to both the patient and the patient’s caregivers. Every effort is needed to assist the patient in comfortable and dignified death. Common symptoms at the end of life include pain, nausea, dyspnea, and, at the very end, a death rattle. Pain is the most common problem and has a multitude of potential approaches. For the dying patient, management with medications is the most common and useful approach. Nausea can be approached with either a standard approach or a mechanistic approach. Dyspnea responds best to morphine or other opioids, and the death rattle, although bothersome to the observer, is not a problem for the patient and there is no good treatment. Patients with intractable pain can benefit from palliative sedation. With proper management, patients should be able to have a comfortable death.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE 2nd, Marcello J, Young IH, Bull J, Wilcock A, Booth S, Wheeler JL, Tulsky JA, Crockett AJ, Currow DC (2010) Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376:784–793
Armstrong SC, Cozza KL (2003) Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I. Psychosomatics 44:167–171
Bandieri E, Romero M, Ripamonti CI, Artioli F, Sichetti D, Fanizza C, Santini D, Cavanna L, Melotti B, Conte PF, Roila F, Cascinu S, Bruera E, Tognoni G, Luppi M (2015) Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol 34(5):436–442, Online pre-print
Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM (2012) Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncol 51:996–1008
Boyden JY, Connor SR, Otolorin L, Nathan SD, Fine PG, Davis MS, Muir JC (2015) Nebulized medications for the treatment of dyspnea: a literature review. J Aerosol Med Pulm Drug Deliv 28:1–19
Bruera E, Miller MJ, Macmillan K, Kuehn N (1992) Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 48:163–166
Bush SH, Kanji S, Pereira JL, Davis DH, Currow DC, Meagher DJ, Rabheru K, Wright DK, Bruera E, Agar M, Hartwick M, Gagnon PR, Gagnon B, Breitbart W, Regnier L, Lawlor PG (2014) Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manage 48:231–248
Cherny NI, ESMO Guidelines Working Group (2014) ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol 25(Suppl 3):iii143–iii152
Cherny NI, Radbruch L, Board of the European Association for Palliative Care (2009) European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23:581–593
De J, Wand AP (2015) Delirium screening: a systematic review of delirium screening tools in hospitalized patients. Gerontologist 55:1079–1099
Diop AD, Fontarensky M, Montoriol PF, Da Ines D (2014) CT imaging of peritoneal carcinomatosis and its mimics. Diagn Interv Imaging 95:861–872
Drummer OH, Syrjanen ML, Phelan M, Cordner SM (1994) A study of deaths involving oxycodone. J Forensic Sci 39:1069–1075
Feuer DJ, Broadley KE (1999) Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Systematic Review Steering Committee. Ann Oncol 10:1035–1041
Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ (1987) Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 66:723–730
Ford AC, Brenner DM, Schoenfeld PS (2013) Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis. Am J Gastroenterol 108:1566–1574
Gaudreau JD, Gagnon P, Harel F, Roy MA, Tremblay A (2005) Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 23:6712–6718
Glare P, Miller J, Nikolova T, Tickoo R (2011) Treating nausea and vomiting in palliative care: a review. Clin Interv Aging 6:243–259
Grassi L, Caraceni A, Mitchell AJ, Nanni MG, Berardi MA, Caruso R, Riba M (2015) Management of delirium in palliative care: a review. Curr Psychiatry Rep 17:550
Gupta M, Davis M, LeGrand S, Walsh D, Lagman R (2013) Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol. J Support Oncol 11:8–13
Hasselstrom J, Sawe J (1993) Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clin Pharmacokinet 24:344–354
Issaka RB, Shapiro DM, Parikh ND, Mulcahy MF, Komanduri S, Martin JA, Keswani RN (2014) Palliative venting percutaneous endoscopic gastrostomy tube is safe and effective in patients with malignant obstruction. Surg Endosc 28:1668–1673
Jannetto PJ, Wong SH, Gock SB, Laleli-Sahin E, Schur BC, Jentzen JM (2002) Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases. J Anal Toxicol 26:438–447
Jin M, Gock SB, Jannetto PJ, Jentzen JM, Wong SH (2005) Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. J Anal Toxicol 29:590–598
Kalso E (2007) How different is oxycodone from morphine? Pain 132:227–228
Laval G, Marcelin-Benazech B, Guirimand F, Chauvenet L, Copel L, Durand A, Francois E, Gabolde M, Mariani P, Rebischung C, Servois V, Terrebonne E, Arvieux C, French Society for Palliative Care, French Society for Digestive Surgery, French Society for Gastroenterology, French Association for Supportive Care in Oncology, French Society for Digestive Cancer (2014) Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manage 48:75–91
Lee D Opiod Potency Comparison. Emedicine Health. http://www.emedicinehealth.com/opioid_potency_comparison/article_em.htm
Lin HS, Eeles E, Pandy S, Pinsker D, Brasch C, Yerkovich S (2015) Screening in delirium: a pilot study of two screening tools, the Simple Query for Easy Evaluation of Consciousness and Simple Question in Delirium. Australas J Ageing 34:259–264
Lokker ME, van Zuylen L, van der Rijt CC, van der Heide A (2014) Prevalence, impact, and treatment of death rattle: a systematic review. J Pain Symptom Manage 47:105–122
Maltoni M, Setola E (2015) Palliative sedation in patients with cancer. Cancer Control 22:433–441
Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, Amadori D, Nanni O (2012) Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol 30:1378–1383
Navigante AH, Castro MA, Cerchietti LC (2010) Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated. J Pain Symptom Manage 39:820–830
Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME (2006) Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 31:38–47
National Comprehensive Cancer Network (2016) NCCN Guidelines Version 1.2016 Palliative Care. National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf
Procon.org (2016) State-by-State Guide to Physician-Assisted Suicide – Euthanasia – ProCon.org.http://euthanasia.procon.org/view.resource.php?resourceID=000132. Accessed 3/20/2016
Roarty TP, Weber F, Soykan I, McCallum RW (1997) Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial. Aliment Pharmacol Ther 11:1059–1066
Sands MB, Dantoc BP, Hartshorn A, Ryan CJ, Lujic S (2010) Single Question in Delirium (SQiD): testing its efficacy against psychiatrist interview, the Confusion Assessment Method and the Memorial Delirium Assessment Scale. Palliat Med 24:561–565
Schrijver EJ, de Graaf K, de Vries OJ, Maier AB, Nanayakkara PW (2016) Efficacy and safety of haloperidol for in-hospital delirium prevention and treatment: a systematic review of current evidence. Eur J Intern Med 27:14–23
Silva AC, Pimenta M, Guimaraes LS (2009) Small bowel obstruction: what to look for. Radiographics 29:423–439
Soffer EE, Metcalf A, Launspach J (1994) Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci 39:929–933
Soriano A, Davis MP (2011) Malignant bowel obstruction: individualized treatment near the end of life. Cleve Clin J Med 78:197–206
Toll L Opiod receptors, introduction. IUPHAR/BPS Guide to PHARMACOLOGY. http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=50
Trescot AM, Datta S, Lee M, Hansen H (2008) Opioid pharmacology. Pain Physician 11:S133–S153
van Eijk MM, Roes KC, Honing ML, Kuiper MA, Karakus A, van der Jagt M, Spronk PE, van Gool WA, van der Mast RC, Kesecioglu J, Slooter AJ (2010) Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 376:1829–1837
Wee B, Hillier R (2008) Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev (1):CD005177
Wilwerding MB, Loprinzi CL, Mailliard JA, O’Fallon JR, Miser AW, van Haelst C, Barton DL, Foley JF, Athmann LM (1995) A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer 3:135–138
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Berk, L. (2017). Symptom Management of the Dying Oncology Patient. In: Berk, L. (eds) Dying and Death in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-41861-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-41861-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41859-9
Online ISBN: 978-3-319-41861-2
eBook Packages: MedicineMedicine (R0)